SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
7TM Pharma Completes Positron Emission Tomography Preclinical Research Program To Successfully Demonstrate Peripheral Restriction Of Its CB1 Receptor Antagonist TM38837